Evidence map›Paper›PMID 29410228›Full record

ArticleBiochimica et biophysica acta. General subjects2018

Facile metabolic glycan labeling strategy for exosome tracking.

Tae Sup Lee, Young Kim, Weiqi Zhang, In Ho Song, Ching-Hsuan Tung

Abstract read
In one paragraph

Article in Biochimica et biophysica acta. General subjects, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Mapping GlycoRNAs on an Exosomal Surface.Journal of the American Chemical Society · 2026
    Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Tae Sup LeeMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA; Division of RI-convergence Research, Korea Institute of Radiology and Medical Sciences, Seoul 01812, Republic of Korea.
Young KimMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA.
Weiqi ZhangMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA.
In Ho SongDivision of RI-convergence Research, Korea Institute of Radiology and Medical Sciences, Seoul 01812, Republic of Korea.
Ching-Hsuan TungMolecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, NY 10021, USA. Electronic address: cht2018@med.cornell.edu.
Weill Cornell Medicine · USCornell University · USKorea Institute of Radiological and Medical Sciences · KR

Funding

Sound excitable drugsR01GM094880 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI TUNG, CHING-HSUAN · 2010 to 2014
$1.2M
NIGMS NIH HHS R01 GM094880
6 · The paper itself

Abstract

backgroundExosomes are nano-sized vesicles derived from the fusion of multivesicular bodies with the surrounding plasma membrane. Exosomes have various diagnostic and therapeutic potentials in cancer and other diseases, thus tracking exosomes is an important issue.

methodsHere, we report a facile exosome labeling strategy using a natural metabolic incorporation of an azido-sugar into the glycan, and a strain-promoted azide-alkyne click reaction. In culture, tetra-acetylated N-azidoacetyl-D-mannosamine (Ac

resultsCellular uptake and the in vivo tracking of fluorescent labeled exosomes were evaluated in various cells and tumor bearing mice. Highly metastatic cancer-derived exosomes showed an increased self-homing in vitro and selective organ distribution in vivo.

conclusionOur metabolic exosome labeling strategy could be a promising tool in studying the biology and distribution of exosomes, and optimizing exosome based therapeutic approaches. GENERAL SIGNIFICANT: A facile and effective exosome labeling strategy was introduced by presenting azido moiety on the surface of exosome through metabolic glycan synthesis, and then conjugating a strain-promoted fluorescent dye.

Indexed as

ExosomesPolysaccharidesAnimalsClick ChemistryFluorescent DyesHexosaminesHumansMCF-7 CellsMiceNIH 3T3 CellsStaining and LabelingFluorescent DyesHexosaminesmannosaminePolysaccharidesCancerClick chemistryDistributionExosomeMetabolic glycan labeling

Identifiers

PMID29410228
PMCPMC5866232
OpenAlexW2792707521

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.